ANDA 211464, held by Padagis Israel. Halobetasol Propionate.
As of Nov 15, 2026, ANDA 211464 (Halobetasol Propionate), held by Padagis Israel, was first approved by FDA on Jun 3, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 3, 2020 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Halobetasol Propionate0.05% ยท lotion;topical | Halobetasol Propionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
